Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001179110-20-012070

EVP/Chief Scientific Officer sold 10,000 shares at an average $63.22 ($632,156)

  • EVP/Chief Scientific Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Albright Charles · EVP/Chief Scientific Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-12-15 Exercise or conversion : show line 1 in the form +10,000 $16.51 $165,100 34,907 D
2020-12-15 Sale : show line 2 in the form −5,776 $62.74 $362,386 29,131 D
2020-12-15 Sale : show line 3 in the form −4,024 $63.84 $256,892 25,107 D
2020-12-15 Sale : show line 4 in the form −200 $64.39 $12,878 24,907 D
Open-market sales · 10,000 sh · avg $63.22 · $632,156

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-15 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −10,000 145,000 D
Loading xslF345X03/edgar.xml…